Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Bad
|
New words:
Africa, amalgamation, Announced, Article, creation, Defeasance, denied, direct, discharge, discharged, disposition, enact, Europe, Exhibit, focused, force, guarantee, guaranteed, Guarantor, indirect, intercompany, irrevocably, IX, Japan, jointly, legislation, list, LLC, longer, mix, network, occurrence, OECD, Organization, parent, Pillar, privilege, Publicly, reconciliation, reduction, reinstated, reinstatement, release, released, reserving, scheduled, substantially, surviving, Topic, unconditionally, understood, Unrestricted, VIII
Removed:
appealing, April, benchmark, bringing, buyer, consistent, decreased, discovery, investor, LIBOR, supplier, thereof, understand, user, working
Financial report summary
?Competition
Teligent • Icon • Neogenomics • Veradigm • Vyant Bio • Veeva Systems Inc - Ordinary Shares • Ironwood Pharmaceuticals Inc - Ordinary Shares • Medidata Solutions • Zyla Life Sciences • PRA Health SciencesManagement Discussion
- Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations
- You should read the following discussion and analysis of our financial condition and results of operations together with our consolidated financial statements and the related notes included elsewhere in this Annual Report on Form 10-K. Some of the information contained in this discussion and analysis or set forth elsewhere in this Annual Report, including information with respect to our plans and strategy for our business, includes forward-looking statements that involve risks and uncertainties. You should read the “Risk Factors” section of this Annual Report for a discussion of important factors that could cause actual results to differ materially from the results described in or implied by the forward-looking statements contained in the following discussion and analysis.
- IQVIA is a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry. IQVIA creates intelligent connections across all aspects of healthcare through its analytics, transformative technology, big data resources, extensive domain expertise and network of partners. IQVIA Connected Intelligence delivers actionable insights and powerful solutions with speed and agility — enabling customers to accelerate the clinical development and commercialization of innovative medical treatments that improve healthcare outcomes for patients. With approximately 87,000 employees, we conduct operations in more than 100 countries.